Pancreatic Cancer Research

ResearcherUniversity of Alabama at BirminghamNo recent work listed

Asmi Chakraborty

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6528-8602; OpenAlex author ID A5040357202. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 3

  1. ST6GAL1 sialyltransferase promotes acinar to ductal metaplasia and pancreatic cancer progression. First author DOI 10.1172/jci.insight.161563↗
  2. Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells. Co-author DOI 10.1074/jbc.ra120.014126↗
  3. ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage. Co-author DOI 10.1074/jbc.m117.808584↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Donald J Buchsbaum · 3 shared papers, 2018–2023 · strength 0.36
  2. Susan L Bellis · 3 shared papers, 2018–2023 · strength 0.36
  3. Colleen M. Britain · 2 shared papers, 2021–2023 · strength 0.27
  4. Austin D. Silva · 2 shared papers, 2021–2023 · strength 0.27
  5. Nikita Bhalerao · 2 shared papers, 2021–2023 · strength 0.27
  6. Christopher Klug · 1 shared paper, 2023 · strength 0.14
  7. Michael P. Marciel · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.